Cases & Deals

  • Home
  • Practices
  • Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Accord Healthcare

Share

Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Accord Healthcare

May 2023

Client(s) Purdue Pharma L.P.

Jones Day represents Purdue Pharma L.P. in asserting patent infringement claims under the Hatch-Waxman Act against generic-drug company Accord Healthcare, Inc. involving several patents directed to OxyContin®. The case is currently on appeal at the Federal Circuit.

Purdue Pharma L.P. v. Accord Healthcare, Inc., No. 1-20-cv-01362 (D. Del.); Appeal No. 23-1953 (Fed. Cir.)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.